Fifth Third Bancorp
CRDF icon

Fifth Third Bancorp’s Cardiff Oncology CRDF Stock Holding History

Fifth Third Bancorp’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$296 – 2390
2023
Q4 		$296 Hold
200
– – ﹤0.01% 2470
2023
Q3 		$278 Hold
200
– – ﹤0.01% 2540
2023
Q2 		$294 Buy
+200
New +$323 ﹤0.01% 2574
2018
Q3 		– Sell
-139
Closed -$1K – 2205
2018
Q2 		$1K Buy
+139
New +$2.32K ﹤0.01% 2227

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return

Fifth Third Bancorp's CRDF Position: Q1 2024 in Review

Fifth Third Bancorp sold out of Cardiff Oncology (CRDF) in Q1 2024, closing a stake of 200 shares — an estimated $296 sold.

Fifth Third Bancorp first reported a position in CRDF in Q2 2018 and held it in 4 quarters. The position peaked at $1K in Q2 2018. 77 funds tracked by Wall St. Rank hold CRDF as of Q1 2024.

  • Fifth Third Bancorp reported no remaining Cardiff Oncology position as of Q1 2024 after selling out during the quarter.
  • Fifth Third Bancorp sold 200 Cardiff Oncology shares in Q1 2024, an estimated $296.
  • Fifth Third Bancorp first reported a position in Cardiff Oncology in Q2 2018 and held it in 4 quarters.
  • Fifth Third Bancorp's Cardiff Oncology position peaked at $1K in Q2 2018.
  • 77 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2024.

Based on Fifth Third Bancorp's 13F filing for Q1 2024, filed 23 Apr 2024.